Results 181 to 190 of about 3,750,719 (375)

Novel 4-benzoylpyridine oxime derivative GIZH-298 with aticonvulsant activity

Фармакокинетика и Фармакодинамика, 2017
Novel derivative of benzoylpyridine oximes - GIZH-298 (4-benzoylpyridine 0-(2-morpholinoethyl) oxime oxalate) was designed and synthesized in this work.
L. A. Zhmurenko, G. V. Mokrov, L. N. Nerobkova, S. A. Litvinova, I. O. Gaydukov, T. A. Voronina, T. A. Gudasheva   +6 more
doaj  

Toxicological evaluation of convulsant and anticonvulsant drugs in human induced pluripotent stem cell-derived cortical neuronal networks using an MEA system. [PDF]

Sci Rep, 2018
Odawara A, Matsuda N, Ishibashi Y, Yokoi R, Suzuki I.   +4 more
europepmc   +1 more source

Levetiracetam: The Profile of a Novel Anticonvulsant Drug—Part I: Preclinical Data [PDF]

, 2007
Tim De Smedt, Robrecht Raedt, Kristl Vonck, Paul Boon   +3 more
openalex   +1 more source

Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders

Medicinal Research Reviews, EarlyView.
ABSTRACT Neuropsychiatric disorders present a multifaceted challenge, characterized by cognitive, social, and motor impairments with manifold underlying mechanisms. Recent attention has turned to epigenetic mechanisms, particularly histone lysine methyltransferases (HKMTs), such as G9a, in understanding fundamental pathogenesis.
Malak Hajar, Tobias Werner, Mihajlo Gajic, Holger Stark, Bassem Sadek   +4 more
wiley   +1 more source

Pain Experiences and Prescription Pain Medications Among People With Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network

Muscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Pain is a recognized symptom of muscular dystrophy (MD), but little is known about prescription pain medications in this population. We describe pain experiences and pain medications prescribed for individuals with selected MDs using population‐based surveillance data collected by the Muscular Dystrophy Surveillance, Tracking,
Jonathan Suhl, Kristin M. Conway, Shiny Thomas, Sonja A. Rasmussen, James F. Howard, Nicholas E. Johnson, Paul A. Romitti, Katherine D. Mathews, The Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet)   +9 more
wiley   +1 more source

This is Your Brain on Drugs: Predicting Anticonvulsant Effect Using Transcranial Stimulation [PDF]

, 2011
Scott Mintzer
openalex   +1 more source

A Systematic Review of Synthetic and Anticancer and Antimicrobial Activity of Quinazoline/Quinazolin‐4‐one Analogues

ChemistryOpen, EarlyView.
Quinazoline represents an important class of heterocycles with diverse medicinal and pharmacological significance. This review systematically examines scholarly efforts toward understanding different synthetic pathways emphasizing the role of metal and non‐metal catalysts including some miscellaneous reagents employed in the synthesis of quinazoline ...
Neha Manhas, Gobind Kumar, Sanjeev Dhawan, Talent Makhanya, Parvesh Singh   +4 more
wiley   +1 more source

Neuromuscular effects of rocuronium in patients receiving beta-adrenoreceptor blocking, calcium entry blocking and anticonvulsant drugs

, 1997
P. B. Loan, F. M. Connolly, R. K. Mirakhur, Nanda Kumar, P. Farling   +4 more
openalex   +1 more source

New Drug Review: Clobazam (Onfi®) - A “new” anticonvulsant option [PDF]

, 2011
Jamie Holmes, Robin Hieber
openalex   +1 more source

Anticonvulsant drugs used in the treatment of lancinating pain. A comparison

Anaesthesia, 1981
M. Swerdlow, J. Cundill
semanticscholar   +1 more source